You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • P286 Cost-consequence of fluticasone furoate/vilanterol 100/25mcg for the management of copd in the spanish nhs: an analysis based on the copd salford lung study

Article info

Article menu

Download PDFPDF

Drugs and Devices in COPD
P286 Cost-consequence of fluticasone furoate/vilanterol 100/25mcg for the management of copd in the spanish nhs: an analysis based on the copd salford lung study
Free

Authors

Citation

Huerta A, Boucot I, Driessen M
P286 Cost-consequence of fluticasone furoate/vilanterol 100/25mcg for the management of copd in the spanish nhs: an analysis based on the copd salford lung study
Thorax 2016;71:A244.

Publication history

  • First published November 15, 2016.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions